









PSYCHIATRIC ASPECTS OF HAEMATOLOGICAL 
MALIGNANT DISEASE THE GROOTE SCHUUR EXPERIENCE 
RAYMOND BERARD 
BSc. M.B.B.Ch. (WITS) D.C.H. (S.A.) M.F.G.P. (S.A.) 
F . F . PSYCH ( S . A . ) 
A Dissertation submitted in partial fulfilment of the 
requirements for the degree of Master of Medicine in 
Psychiatry. 
Department of Psychiatry 
University of Cape Town 
1992 
The copyright of this thesis vests in the author. No 
quotation from it or information derived from it is to be 
published without full acknowledgement of the source. 
The thesis is to be used for private study or non-
commercial research purposes only. 
Published by the University of Cape Town (UCT) in terms 











I would like to thank the staff in the departments of 
Haematology and Radiotherapy for their assistance and 
support during the study period. 
A special thanks to Mrs. Ilse Stander Biostatics Dept., 
Medical Research Council, Parow, for her patience and 
assistance in analysing the data. 
I am grateful to Mrs Phillipa Johnson Medical Graphics 
Dept. , Groote Schuur Hospital, for her assistance with 
the preparation of the tables. 
CONTENTS. 
1. LITERATURE REVIEW: 
1.1 Introduction 
1. 2 The Socioeconomically Disadvantaged 
1. 3 Mood Problems in Cancer 






2.2 Aims and Hypotheses 









3.03 Employment Status 
3.04 Educational Status 
3.05 Previous Psychiatric contact 
3.06 Significant Psychological Reaction not classified 
in the DSM IIIR. 
3.07 Axis 1 Psychiatric Diagnosis 
3.08 Pain as a Major Presenting Factor 





















3.10 Psychotropic Usage 
3.11 Psychological Intervention (Haematological Group) 
3.12 Physical outcome 
3.13 Psychological Outcome 




4.03 Employment status 
4.04 Educational Status 
4.05 AXis 1 Psychiatric Diagnosis 
4.06 Significant Psychological Reaction not classified 
in DSM IIIR. 
4.07 Pain as a Major Presenting Factor 
4.08 Psychosocial Stressors 
4.09 Psychotropic Usage 
4.10 Psychological Intervention 
4.11 Physical Outcome 

























The discipline of liaison psychiatry is relatively new 
particularly in the South African context. The entrance 
of liaison psychiatry into the domain of oncology began 
in earnest in the 1950s, and an interest in the 
psychosocial aspects has mushroomed in the last decade 
with improved research methodology (1). It currently 
faces the task of more firmly establishing its role 
within the entire health care system. Mc Kegney and 
Beckhardt feel its acceptance by the health care system, 
and physicians in particular will depend upon scientific 
demonstration that psychosocial factors influence 
biologically defined medical illness (2). 
2 major research domains appear to have evolved: 
# cancer control and epidemiology. 
# psychosocial and psychoneuroimmunology. (1) 
According to Holland (1) there are 5 main areas of 
psychosocial impact on the morbidity and mortality of 
cancer patients. These are: 
1. Lifestyle and behaviours. 
2. Social environment. 
3. Personality and coping. 
4. Affective states/life events. 
5. Psychosocial/behavioural interventions. 
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systematic research in these areas is providing an 
increased understanding 
cancer patients and the 
of the psychosocial needs of 
effectiveness of appropriate 
intervention particularly in terms of relieving 
unnecessary stress and improving quality of life. 
There are an increasing number of papers discussing the 













psychological problems fell into three main categories: 
1. Cerebral complications of malignant disease. 
2. Coincidental psychiatric disorder. 
3. Psychological reaction to malignant disease. 
In the latter group there was a high level of Affective 
Disorder and transient psychological reactions. Ramirez 
maintained that there was a low rate of ref err al. The 




An inability of medical 
psychological morbidity. 
The low priority given 
intervention. 
A reluctance of patients 
psychiatric morbidity. 
staff to recognize 
to psychological 
to disclose their 
2 
3 
Ramsay ( 4) while agreeing with the above emphasizes the 
fact that the majority of referrals in his sample 
presented with an adjustment disorder/problem. The 
author agrees that physician underreporting is a problem. 
The issue of continuity of care is stressed (4). 
Meerwein (5) points out a number of important issues when 
working in this field: 
1. It is important for a psychiatrist working in this 
environment to be cognizant of the fact that one is 
not in competition with his oncology colleagues. 
Roles and functions are different. 
2. It is important for the Liaison Psychiatrist to 
emphasize that he views the majority of cancer 
patients as psychically healthy and that their 
psychological equilibrium has possibly been 
disturbed by the onset of the illness. 
3. Beware of patients masking the outward expression of 
their feelings. 
4. Cancer patients often regress emotionally as part of 
their reaction to the illness. 
5. The oncology staff may become jealous of the 
relationship between patient and psychiatrist. It 
4 
is important to recognize this perceived threat and 
confront fears and suspicions. 
Exploring psychosocial issues requires a 
multidisciplinary approach (5). The team includes a 
psychiatrist, psychologist; psychiatric nurse-clinical 
specialist and social worker. The training of the 
psychiatrist allows him to review the interaction of 
biologic and psychosocial factors in each patient. The 
unique contribution of the psychologist is in the area of 
behaviour modification techniques and self -regulatory 
therapies (relaxation and biofeedback) and 
neuropsychiatric testing. Many have an additional 
interest in research methodology. The psychiatric nurse-
clinical specialist concentrates her efforts on the 
nursing staff, helping them to become more objective and 
provide better care. The social worker is most familiar 
with community resources and issues involving financial 
aspects of heal th care. Hence this member plays and 
important role in patient rehabilitation. The author 
feels that the social worker can play a role in therapy 
particularly family work. Proper training and 
supervision must be available. 
Goldberg (6) stresses the importance of properly defining 
roles and avoiding competitiveness. 
is important to recognize this perceived threat and 
confront fears and suspicions. 
Exploring psychosocial issues 
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The author ( 6) advocates the use of a biopsychosocial 
database which he feels is the fundamental clinical tool 
to assure a systematic approach to patient care. This 
attention to multiple dimensions also ensures that the 
crucial psychosocial factors will not be discounted by an 
excessively biomedical viewpoint. Elements that must be 
included in any basic history are: 
# past psychiatric history 
# significant life events 
# family history 
# medical history including habits and current 
medication. 
Gonda (7) looks at the psychosocial considerations in the 
treatment of leukaemia. They are not dissimilar to those 
inpatients with non-haematological cancer. Modern 
chemotherapy leads to considerable difficulty in 
adjusting to treatment-related debility and loss of 
control. Another concern is the tendency of leukaemia to 
follow a path of remission and exacerbation which leads 
to uncertainty about course and outcome. Finally like 
other malignancies, it is difficult to distinguish the 
effects of the illness and its treatment from frank 
depression. The author feels that the following points 
suggest a mood disorder: 
# a sense of hopelessness and helplessness. 
# slowed thinking and speech. 
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# rumination about suicide and unremitting blackness of 
mood that is not even lightened by previously pleasurable 
activities. 
Psychiatric morbidity is uncommon in patients with 
cancer. The majority of patients present with adjustment 
problems associated with their illnes, its investigation 
or treatment ( 1) . Symptoms (particularly of depression) 
are often masked. Staff are often unaware of 
psychological problems which seem to have a low priority 
in the overall care of the patient with malignant 
disease. 
1.2 THE SOCIOECONOMICALLY DISADVANTAGED. 
Poverty is associated with lack of education, 
unemployment, substandard housing, risk-prompting 
behaviour and lifestyle, and diminished access to health 
care (8). According to Freeman all the above contribute 
to decreased survival. Poor people tend to concentrate 
on day-to-day survival, often develop a sense of 
hopelessness and powerlessness, and become socially 
isolated. Kerner ( 9) maintains that the gap between 
interventions for the SEO and the middle and upper 
classes is growing and that the majority of these 
interventions are researched in this latter group. 
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Kerner (9) states that the major identifiable preventable 
risk factors in cancer are smoking, diet and 
accessibility to screening. The Tobacco Industry targets 
the SEO group which has higher rates of smoking compared 
with the rest of the population. High bulk foods tend to 
be unaffordable. Screening is either 
inadequate. Educational programmes 




needs of the 
Improved funding of research in the SEO group is a 
priority. 
1.3 MOOD PROBLEMS IN CANCER. 
Dean et al (10) feel that the majority of cancer patients 
have minor affective illness and in his series only 5% 
required active treatment. They 
attached to psychiatric referral. 
the difficulty distinguishing 
emphasize the stigma 
The authors mention 
between appropriate 
They emphasize the 
morbidity and the 
distress and significant depression. 
importance of previous psychiatric 
likely predisposition to recurrence. 
Dean maintains that adequate social support is important 
and must be assessed. He feels that psychological 
assessment is important as active intervention may alter 
the prognosis. 
7 
Massie and Holland (11) in their paper stress that only a 
small percentage have preexisting affective disorder. 
They feel that during clinical evaluation it is important 
to assess if there is a history of previous depressive 
episodes, family history of depression or suicide, 
concurrent life stress, and availability of social 
support. 
The authors emphasize that 
neurovegetative symptoms as they 
with the disease process itself. 
one 
are 
cannot rely on 
commonly associated 
Peteet (12) describes 3 types of depressive reactions in 
cancer patients: 
# the transient stress reaction 
# the major psychiatric disturbance requiring prompt 
specialized attention 
# and a miscellaneous group where charactological, 
interpersonal and organic factors operate. 
He feels that shock, anxious distress, and emotional 
turmoil at the point of diagnosis; discovery of a 
worsened prognosis; or loss of valued functions are 
typical reactions displayed by the cancer patient. These 
may be accompanied by anger, withdrawal, tearfulness, and 
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insomnia but not typically persisting vegetative 
symptoms, social withdrawal, or suicidal ideation. 
Evans and associates (13) unlike the above feel that 
Major Depression is common in 
frequently goes unnoticed and is 
cancer patients and 
inadequately treated 
when diagnosed. The authors then discuss the diagnostic 
pitfalls particularly the problem of neurovegetative 
symptoms. They claim that suicidal ideation is uncommon 
in cancer patients. They also unlike others advocate 
greater use of antidepressants at full therapeutic doses. 
There are certain areas that need to be explored when 
assessing a cancer patient for depression. 
Hopwood and Maguire (14) emphasize the importance of 
exploring the issue of body image. The effects of 
of therapeutic 
effect on the 
malignant disease and the various modes 
intervention often have a profound 
physical appearance of the patient. This may lead to 
changes in self concept and associated undesirable 
alterations in behaviour. They explored the effect of 
breast removal on sexual behaviour. They concluded that 
patients who fail to adapt to loss of a body part or 
function as a result of cancer or its treatment seriously 
compromise their quality of life during survival. This 
disturbance of body image frequently contributes to the 
development of an affective disorder. 
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Another important area that must be explored is the issue 
of pain. Breithart (15) contends that pain is a feared 
consequence of cancer. Noyes ( 16) 
some useful general principles for 
He maintains that pain falls 
categories: 
1. Pain caused by the cancer. 
2. Pain caused by cancer therapy. 
in his review gives 
assessment of pain. 
into 3 aetiologic 
3. Pain unrelated to the cancer or its therapy. 
The author emphasizes that it is important to treat pain 
adequately before diagnosing depression as many of the 
symptoms associated with chronic pain mimic those of 
major affective disorder. 
Forman (17) agrees with Evans (13) that suicidal ideation 
is uncommon in cancer patients. The suicide rate amongst 
these patients is surprisingly low. Forman maintains 
that the cancer patient who does commit suicide is likely 
to have been in the late stages of his disease and to 
have given signals of poor psychologic resources and 
limited ability to adjust to illness. 
Massie and Holland ( 11) concur stating that there is a 
higher rate of suicide associated with poor prognosis, 
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prior psychiatric history, and a history of previous 
attempts or a family history of suicide. 
In addition, the recent death of friends or spouse, few 
social supports, depression (particularly when 
hopelessness is a key feature), poorly controlled pain, 
delirium, and recent information about a grave prognosis 
are significant risk factors. 
1.4 STRESS IN THE CANCER PATIENT. 
Redd and Jacobsen (18) divide current issues in 
psychological factors and cancer into 3 categories: 
1. The role of psychological factors in disease 
promotion and progression. 
2. The impact of neoplastic disease and its treatment 
on psychological functioning. 
3. The long-term impact of cancer and cancer treatment 
on the survivor and issues of family bereavement 
following the death of a cancer patient. 
According to the authors psychosocial risk factors 
include stressors encountered, underlying personality 
traits or coping styles, and personal habits. 
According to Lesko and Holland ( 19) the normal concerns 




# dependency on family, spouse, and physician, balanced 
against the need for independence 
# disfigurement and changes in body appearance and self 
image, sometimes in loss or changes in sexual functioning 
# disability that interferes with achievement of age 
appropriate tasks in work, school or leisure roles 
# disruption in interpersonal relationships 
# discomfort and pain in the later stages of illness 
# disengagement towards reentry into a near-normal 
lifestyle (survivorship). 
The patient's ability to manage these stressors depends 
on the following factors: 
1. The disease itself. (ie. symptoms, clinical course, 
type of treatment required, number of relapses.) 
2. The level of adjustment, especially prior to medical 
illness. 
3. The threat cancer poses in attaining age appropriate 
development tasks and goals. 
4. The presence of emotionally supportive persons in 
the patient's environment. 
5. Cultural and religious attitudes. 
6. The patient's potential for physical and 
psychological emotional rehabilitation. 
7. The patient's personality and coping style. 
The authors go on to discuss the 2 most important 
psychological sequelae in haematological malignancies 
namely anxiety and depression. 
They emphasize situations where acute anxiety is likely 
to occur in the course of the illness: 
# while awaiting the diagnosis of cancer 
# while awaiting procedures 
# prior to major treatment 
# while awaiting test results 
# upon learning of relapse 
# upon change of treatment 
# on the anniversary of illness related events. 
According to the authors depression is related to 
stressors with cancer. They also mention the role of 
medication, biologically determined depression and 
bipolar illness in the cancer setting. 
Weismann ( 2 O) in his paper points out that diminished 
distress improves coping skills, allowing the patient to 
become a more active participant. 
The author describes 2 types of vulnerability namely, 
dysphoria or dispositional. Dysphoria refers to the 
affect observed. It relates to the distress or pain the 
patient is experiencing at the time. Disposition refers 
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to the plight or predicament the patient finds himself in 
at the time. Assessment of these 2 factors according to 
the author allows one to reduce the level of stress and 
improve coping skills. 
The importance of adequate· assessment of stress in the 
patient is illustrated in a paper by Irwin (21) who 
reports an episode of a Brief Reactive Psychosis in a 13 
yr. old boy with leukaemia. Increased awareness and 
better monitoring of the situation could possibly have 
prevented this outcome. 
Ell, Nishimoto et al ( 22) discuss the issue of 
survivorship and the importance of quality of life which 
is gaining more prominence with improved physical 
treatments and outcome. 
They found that the psychological status of patients 
three or more years after the diagnosis is similar to 
that found in the general population. However there is a 
group of patients (approximately 20% to 30%) who continue 
to experience clinically significant distress and poorer 
wellbeing long after the diagnosis. Undoubtedly illness-
related factors account for ongoing distress among these 
patients, but psychological factors such as coping 
resources and life stressors unrelated to cancer are 
important and may vary over time. 
Illness related factors included: 
# frequency of physical symptomatology 
# role functioning limitations. 
Psychosocial factors included: 
# personal sense of control 
# social support 
# life stressors unrelated to cancer. 
The authors conclude that repeated psychological and 
quality of life assessments are needed to monitor 
accurately the patient's ongoing adaption. 
Donavan and associates (23) emphasize the importance of 
accurately measuring all domains of life that are 
impacted by cancer and its treatment. They reiterate the 
usefulness of a biopsychosocial model. 
In the physical domain quality of life is impacted by 
symptoms, 
due to 
loss of function, and curtailment of activity 
disease process and the physical effects of 
treatment. 
In the psychosocial domain the authors identified 5 major 
emotional themes: 
1. The fear and anxiety generated by the diagnosis and 
compounded by inadequate communication with 
caregivers. 
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of personal control associated 




3. The uncertainty about outcome. 
4. The physician's persistent enthusiasm for cure. 
5. The debilitating effects of standard treatments. 
Other causes of anxiety include persistence of symptoms, 
relentless progression of treatment, insecurity when 
treatment is stopped, having to wait for results of 
tests, hair loss, alteration in body image, and reduced 
sexual libido and sexual activity. Other anxieties not 
directly associated to the illness relate to work, 
family, unrealized goals, and financial difficulties. 
The need for clarification about personal responses to 
the situation are appropriate. 
In the social sphere these patients frequently need 
increased support. 
In summary stress is an important factor in cancer in 
terms of the aetiology of cancer 
the unsubstantiated in the human model) , 




vulnerability and coping ability, and finally its effect 
on quality of life in the area of survivorship and 







care has become a central issue in cancer 
Winchester in his paper (24) maintains that 











2. Care and compassion. 
3. Co-ordination of care eg. the multidisciplinary 
team. 
4. Cost effectiveness. 
5. Consumerism. What do patients want? Is what they 
want being delivered? Is it being delivered 
effectively? Are the patients really in a position 
to judge what they want and how it is delivered? 
How are we going to carry out consumer ratings.? 
He emphasizes that it is important that we are able to 
monitor the quality and remember that quality is a by-
product of both process and outcome. 
According to Wells (25) the care of the patient with 
malignancy spans 3 broad areas: 
1. Prevention and screening. 
17 
2. Diagnosis and treatment. 
3. Terminal care or the treatment of patients with 
recurrent or advanced disease. 
The above model can be applied to the psychosocial 
setting. Stam HJ; et al {26) and Worden and colleagues 
(27) show that the options for assessing patients with 
psychosocial problems involve the following: 
1. See every patient following diagnosis. This 
strategy is expensive and does not acknowledge the 
fact that some patients cope very well without 
requiring 
may have 
any special assistance. These 
difficult moments eg. at the 
patients 
time of 
diagnosis or at the time of recurrence, for the most 
part they require little or no special intervention. 
2. screen patients using some reliable, valid, and 
sensitive assessment instrument to identify those at 
high risk. The authors are at odds on this approach 
as Stam et al {26) feel it is expensive. Worden and 
associates {27) feel that identification of this 
group allows an effective strategy to be 
implemented. The main aim of intervention is the 
relief of distress and the improvement of coping 
skills. 
Worden et al {27) in their study divided patients 
following screening into 2 groups, viz 
distress and Low emotional distress. 
High emotional 
The aim of 
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intervention in the former was to lower levels of 
distress, correct deficits in coping, reclaim personal 
control, and improve morale and self esteem. The 
intervention group did not have significantly more 
problems than the low distressed patients, but showed an 
inability to generate a number of alternate coping 
strategies and seemed to overuse ineffective strategies. 
The results showed that the intervention group with the 
same level of stress at the time of screening had 
significantly lower emotional distress at each follow-up 
assessment. 
3. Wait for problems or crises to occur and have 
patients referred to an available resource. 
Referral usually takes place at the time that: 
# a problem is perceived 
# patients themselves or family request some form of 
psychosocial assistance 
# the medical staff perceive or detect problems or a 
crisis. 
Stam and associates (26), Massie and Holland (11}, and 
others discuss the difficulty utilizing the DSM IIIR as a 
diagnostic tool in this setting. The manual does not 
take into account the actual process of the illness or 
its physical management. Stam emphasizes the point that 
a narrow focus on DSM IIIR categories in psychiatric 
screening studies misses the fundamental distinction 
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between a chronic illness population and a normal 
population and attributes greater distress 
patients than in fact may exist. Massie (28) 
to cancer 
and other 
authors mention its shortcomings particularly in the area 
of mood disorders with its emphasis on neurovegetative 
symptoms. 
Ford (29) discusses the importance of the 
multidisciplinary team approach to facilitate proper 
utilization of available manpower resources to maximize 
the potential of care. 
He also feels that there needs to be a greater emphasis 
on the availability of community care facilities. 
Conkling ( 3 o) feels that if care is defined as 
comprehensive it must be continuous. The problems 
associated with the diagnosis and treatment of cancer are 
multifaceted and sometimes complex. These problems 
require thoughtful intervention. Failure to understand 
the issues surrounding the diagnosis and treatment of the 
cancer patient can greatly inhibit the ability of 
patients to function normally, to acquire the multiple 
services necessary to maintain optimal quality of life, 
and to cope with the ultimate crisis of terminal illness. 
The challenge as the author sees it is to ensure 
continuity of care as patients are diagnosed, enter the 
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acute care setting, progress through that setting, and 
then move out to home or institutional settings in the 
community. 
Kobasa ( 31) looked at how patients perceive their care. 
He states that medical staff significantly affect this 
perception by their own handling of the situation. In 
the Memorial Sloane Kettering Study an active stress 
management programme for staff was shown to significantly 
improve patient perceptions of the quality of their care. 
In terms of assessment Maguire and Faulkner (32) discuss 
3 issues which they feel are particularly pertinent 1n 
the cancer patient namely: uncertainty, collusion and 
denial. 
Uncertainty often 
confusion both on 
leads to unnecessary 
the part of the patient 
worry and 
and family. 
The ability of the patient to tackle issues improves when 
one separates out and explores individual concerns. 
It is important to acknowledge the collusion and then to 
explore and validate it. The main effects of a collusion 
on the patient are increased stress and decreasing 
communication often leading to a perceived barrier in the 
relationship. They maintain it is important to break the 
collusion before it becomes a problem. 
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Patients use denial when the truth is too painful to 
bear. Denial should not be challenged unless it is 
creating serious problems for the patient or relative. 
According to the authors a useful method is to go over 
and explore the events leading up to the present time. 
The patient often oscillates between denial and awareness 
and one should check for a window. 
The main thrust of pharmacological intervention is in the 
area of organic mental disorder, mood disorder and 
anxiety. Psychotropics play an important role as an 
adjunct in the management of pain. 
Delirium is not uncommon particularly in the terminal 
stages of illness. Massie, Holland and Glass (33) feel 
that the incidence is underreported and that it is common 
in the terminal stages of cancer. In their sample they 
report an incidence of 85%. They maintain that it is 
difficult to isolate a single cause. They emphasize the 
importance of adequate management to alleviate 
unnecessary distress to both patient and family. Massie 
(28) & (33) recommends the use of psychotropics. The 
author advocates the use of haloperidol. If there are 
problems with extrapyramidal side effects then one can 
use either thioridazine or trifluperazine. 
The most common psychiatric disorder seen in malignant 
disease is depression. Prior to starting an 
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antidepressant it should be borne in mind (11&28) that 
the majority of patients diagnosed as depressed have an 
adjustment disorder. 
In terms of process one should be aware of the patients 
disease status at the time of assessment. They recommend 
the use of standard antidepressants including newer 
agents such as fluoxetine. The authors feel that for 
reasons that remain unclear depressed cancer patients 
often show a therapeutic response to a tricyclic at much 
lower doses. 
Massie (28) discusses the Sloane Kettering experience 
with psychostimulants particularly methylphenidate. The 
author maintains that these drugs promote a sense of 
well-being, decrease fatigue, and stimulate appetite in 
low doses. 
Brief mention is made of benzodiazipines particularly the 
use of alprazolam when anxiety is a component of the 
depression or adjustment problem. 
There is little in the literature concerning the 
pharmacological management of anxiety. Most anxiety in 
the cancer setting according to Massie {28) is acute and 
related to the stress of cancer and its management. Most 
of the emphasis seems to be in the area of anticipatory 
nausea and 
chemotherapy 





lorazepam has been shown to be effective in this setting 
( 3 4 & 3 5) . In the field of chronic anxiety, standard 
treatment regimens are used. 
It is important to mention the use of psychotropics as 
adjuvants in the management of pain. Foley (36) and 
associates ( 3 7) discuss an approach to pain management 
and the use of adjuvant therapy. The authors feel that 
the antidepressants particularly the tricyclics are the 
most useful psychotropic drugs in pain management. Of 
note is the impression that the "analgesic" action comes 
on earlier and is independent and separate from any 
antidepressant effect. 
Some of the neuroleptic group of drugs eg.thioridazine, 
are thought to potentiate the action of narcotic 
analgesics. 
Narcotic analgesics can 




and in the 
debilitated cancer patient. Neuroleptics are useful in 
the management of this complication. 
There is considerable literature on the use of various 
psychotherapeutic modalities in the area of general 
medicine. Much is based on case reports and empirical 
observation. 
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Linn {38) mentions the importance in dealing with cancer 
of taking into account the stage of the illness, physical 
disability, and morbidity associated with cancer 
treatment. The author briefly looks at the different 
psychotherapeutic interventions available namely: 
individual, group, family and behavioural techniques. 
The type of intervention is often determined by the 
patients needs at the time of assessment. 
Forester and associates {39) looked at an unstructured 
psychotherapeutic intervention in patients undergoing 










depression, and social 
of radiotherapy. The 
included catharsis, 
interprative work and education/information. The results 
in this study showed that patients undergoing 







and maintain that the 
psychological needs of these patients must be met. They 
then explore an integrative system of psychotherapy 
looking at different patient/family needs at different 
stages of the illness and its management. The authors 
explore for example the usefulnes of crisis intervention 
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at the time of diagnosis or family therapy particularly 
when dealing with younger cancer patients. 
The two models that have received considerable attention 
in the literature are crisis intervention and adjuvant 
psychotherapy developed by Greer and associates (41). 
Crisis intervention in cancer patients has been developed 
over a number of years. Campone and col leagues ( 4 2) 
reviewed its impact in the cancer setting over a decade 
ago. The aim is to direct attention to the problem at 
hand, restore the individual to precrisis levels of 
functioning and to elicit adaptive coping mechanisms. 
The intervention should be time limited, problem focused 
and allow attainment of specific, situationally 
appropriate goals. 
The authors present a functional model which they feel 
should focus on: 
# the unique meaning of cancer to the individual 
# previous stressful experiences 
# usual methods of coping 
# and support systems presently available. 
The intervention should focus on: 
# shaping reality based expectations 
# adequate information processing 
# encouraging adaptive behavioural change 
# integration 
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# assistance with stress resolution leaving the patient 
with a sense of accomplishment and an internalized sense 
of control. 
Adjuvant psychotherapy APT (41) is an adaptation of the 
crisis intervention model. The aim is: 
# to reduce psychological symptoms associated with 
cancer, particularly depression and anxiety 
# to improve mental adjustment to cancer by inducing a 
positive fighting spirit 
# to promote in patients a sense of personal control 
over their lives and active participation in the 
treatment of their cancer 
# to develop effective coping strategies for dealing 
with cancer-related problems 
# to improve communication between patient and his 
support system 
# to encourage open expression of feelings, particularly 
angry and negative feelings. 
Sessions are structured hourly over 6 - 12 weeks. The 
patients are given regular homework assignments to 
facilitate the learning of new coping skills. 
Greer and associates (43&44) developed the concept of 
fighting spirit and its importance on outcome. Their 
work seems to demonstrate that APT leads to increased 
quality of life and improved survival. 
27 
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Spiegel and associates (45 & 46) using group therapy in a 
sample of patients with metastatic breast cancer 
demonstrated improved quality of life and survival as 
compared with a matched control. They felt that the 
important factors operating were adequate social support 
and the effectiveness of group therapy itself in 
promoting cohesiveness, support and improved coping 
skills. 
Fawzy and colleagues (47, 48 & 49) recently demonstrated 
the effectiveness of a structured group intervention on a 
sample of melanoma patients with non metastatic disease. 
Of note is the fact that, not only did the patients 
demonstrate improved quality of life by way of decreased 
levels of distress and improved coping skills but using 
certain parameters there appeared to be improved immune 
function. 
over a 
Furthermore the gains seemed to be sustained 
considerable period despite no further 
intervention. 
Bos-Branolte and associates (50) demonstrated the 
improved psychological status and functioning in patients 
with cured gynaecological cancers with the introduction 
of psychological intervention. They emphasize the 
importance of survivorship and feel this group of 
patients need more attention. 
Peteet and associates (51) look at the concept of support 
in their paper. They distinguish 4 principal meanings: 




Strengthening. This emphasizes the need for 
adequate structuring in delivering healthcare. The 
onus of this form of support falls largely on the 
multidisciplinary team. 
Maintenance. 
in a state 
This involves maintaining the patient 
of equilibrium and prevention of 
decompensation. 
4. Advocacy. To advocate or promote the patient's 
interests. 
Most authors agree that adequate social support is 
essential in the management of cancer patients. Goldberg 
and Wool (52) maintain that it is not enough to mobilize 
the patient's support system but that to function 
effectively a member(s) may need psychological 
intervention. 
They looked at a group of spouses in patients with lung 
cancer. It was felt that well meaning family members may 
either not know how to offer emotional support or have 
great difficulty in providing that support. Their study 
did not substantiate this hypthosis. The experimental 
group consisted of spouses who received education and 
were offered support in handling their partners and their 
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illness. No difference between the control and 
experimental group was found. The authors feel that 
blanket policies of intervention are time and energy 
consuming and that adequate screening is essential. 
Much has been written on the topic of terminal care. 
Stedeford and workers (53) found that requests for 
psychiatric consultation in the terminally ill were for: 
# failure in communication 
# depression, anxiety or delirium. 
Their intervention led firstly to better pain control and 
diminished depression and anxiety and secondly to 
improved communication between patient and family with 
resultant improved support and understanding. 
Stedeford (54) in another paper explores the major 
defensive mechanisms in terminal cancer patients namely 
denial, displacement, projection and regression. He 
emphasizes the importance of establishing a good rapport 
with these patients in order to prevent the establishment 
of maladaptive defences which may hamper treatment or 
interfere with patient communication. 
The author elaborates on the concept of denial 
maintaining that it is problematic when it interferes 
with communication or treatment to the extent that the 
patient may endure unnecessary pain and suffering. 
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He explores the 
attainable goals. 
concept of hope and the principle of 
The author feels that the withholding 
of information about prognosis when a patient is seeking 
it denies him/her something that is essential if he/ she 
is to do the work of rounding off his/her life in a 
fulfilling way. 
Pasnau and associates (55) look at the role of the 
physician 
guidelines. 
in bereavement and offer 
In terms of attitude it is 
some useful 
important that 
the physician sees death as inevitable and that it is not 
an indictment on his/her competence. 
They explore the normal reactions of: 
# shock and disbelief 
# developing awareness of the loss 
# and restitution and recovery. 
The authors then mention the abnormal 
reactions: 
1. Overreacting without a real sense of loss. 
bereavement 
2. Acquisition of symptoms belonging to the last 
illness of the deceased. 
3. Intensified psychophysiological reactions, including 
asthma and rheumatoid arthritis. 
4. Alterations in relation with friends and relatives. 
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5. Furious hostility against specific persons (often 
physicians). 
6. Repression of hostility leading to a wooden and 
formal manner. 
7. Activities detrimental to their own social and 
ecomomic existence. 
8. Agitated depression. 
They then explore the role of the physician prior to, at 
the time of, and after the patient's death. They 
emphasize the importance of availability, awareness and 
sensitivity to patient and family needs. 
1. 6 CONCLUSION. 
Current thinking advocates adequate psychiatric screening 
of cancer patients to identify those in need of further 
assessment and intervention. Screening can also act as 
a useful method for monitoring patient progress. A 
biopsychosocial model is recommended as an approach. 
Adequate assessment is stressed realising the limitations 
of diagnostic tools such as the DSM IIIR in the cancer 
setting. 
A multidisciplinary team approach is advocated to 
adequately address the psychosocial needs of the cancer 
patient. 
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Preventative screening and educational 
are frequently inaccessible or unavailable. 
facilities are poor and psychosocial issues 
unaddressed. A plea is made for increased 
allocation of research funding in this area. 
Specific psychiatric diagnostic categories are discussed 
in some detail. The majority of workers agree that 
depression is the most common diagnosis encountered in 
the cancer patient particularly Adjustment Disorder. 
Diagnostic pitfalls are emphasized particularly in the 
area of mood disorder where one cannot rely on the 
neurovegetati ve symptom component. Adequate control of 
pain in cancer patients is stressed before one can 
properly assess mood state. 
The significance of 
and the effect of 
susceptibility to 
stress is discussed at some 
vulnerability in increasing 





Pharmacological approaches are discussed. Research 
literature in the use of psychotropics in oncology 
appears sparse and firm conclusions are difficult to 
arrive at. It is suggested that antidepressants can be 
prescribed at half the dose required in the physically 
heal thy adult population. The use of low dose 
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psychostimulants in the treatment of depression is 
mentioned. The tricyclic group of antidepressants are 
regarded as a valuable adjunct in the management of 
cancer pain. The benzodiazepine lorazepam has been shown 
to be useful in the area of anticipatory nausea and 
vomiting in cancer patients undergoing radiotherapy 
and/or chemotherapy. 
In terms of researched psychological intervention the 
main areas of interest seem to involve crisis 
intervention, adjuvant psychotherapy and group therapy. 
Psychological intervention is felt to have a significant 
impact in the areas of improved quality of life (by way 
of relieving distress) , improving coping strategies and 
more tentatively, improving outcome in terms of 
longevity. 
The importance of social support is stressed particularly 
in the areas of diminished psychological morbidity and 
improved quality of life. 




A descriptive analysis using the DSM IIIR of patients 
with haematological malignant disease referred by the 
Dept. of Haematology, Groote Schuur Hospital was carried 
out over a 2 year period. 
with a group of patients 
These patients were compared 
referred by the Dept. of 
Radiotherapy, Groote Schuur Hospital. 
All patients interviewed were subjected to a standard 
psychiatric assessment and then allocated diagnostic 
categories according to DSM IIIR criteria. 
The referral source was unaware that patients assessed 
were part of a prospective study so as not to bias the 
sample in any way. 







took part in 
to the Dept. of 
the intervention 
strategies designed for each patient assessed. 
2.2 AIMS AND HYPOTHESES. 
The first aim of the study was to demonstrate the 
incidence of psychiatric morbidity in patients at Groote 
Schuur Hospital with haematological malignant disease and 
assess the usefulness of the DSM IIIR as diagnostic tool 
in this situation. The hypothesis being that the 
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psychiatric morbidity will follow trends reported 
elsewhere in the literature and that the DSM IIIR will be 
of limited value in this setting. 
Secondly I compared the patients with haematological 
cancers to those with non-haematological malignant 
disease. The underlying hypothesis is that psychiatric 
morbidity between the 2 groups will be similar. 
Thirdly an analysis of the impact of psychiatric 
intervention in terms of time effectiveness and outcome 
was carried out. The hypothesis is that psychiatric 
intervention is time effective and prevents deterioration 
in terms of psychological morbidity. 
2.3 STUDY DESIGN. 
The age of the acute leukaemia group and the carcinoma 
(primary and metastatic) was subjected to non-parametric 
analysis of variable procedure (Wilcox 2 sample test.) . 
The remainder of the data was subjected to a descriptive 
analysis using frequency tables because the group sizes 
were too small. 
The only ethical issue to consider was that staff and 
patients were unaware that these referrals were part of a 
prospective study. I felt that this might bias the 
36 
referral sample thereby not accurately reflecting the 
situation as it exists. 
All patients following interview were discussed at 
clinical meetings with prior patient consent as an 
educative exercise and to plan management. 
Confidentiality was respected insomuch as all information 
the patient wanted withheld from the post-interview 
clinical meeting was not presented. A new folder on all 
patients seen was opened and filed separately. I was the 
only person with ready access to this information and no 
psychiatric notes were written in the hospital folder. 
All patients were allocated a number for the purpose of 
data analysis and remained anonymous. 
2.4 PATIENTS AND METHODS. 
The first sample included all patients referred to me 
personally over a 2 year period for psychiatric 
assessment by the Dept. of Haematology, Groote Schuur 
Hospital. The population included both inpatients and 
outpatients. The referral agent was unaware that these 
patients were part of a prospective study. All patients 
were ref erred for psychiatric assessment by members of 
the clinical haematological staff. 
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There was no age or sex restriction on the patients 
referred to me. Forty three patients with haematological 
malignant disease were assessed by me for the purpose of 
this study. The diagnostic categories were as follows: 
Acute Leukaemia: 23 patients. 





* Four patients with Lymphoma were seen in the Dept. of 
Radiotherapy. 
All patients were subjected to a standard psychiatric 
diagnostic interview. The identifying data was recorded. 
The clinical material obtained from the interview was 
analysed using the DSM III R criteria for diagnosis. 
The patients were then divided into 3 groups: 






monitored by haematological staff 
feedback meetings and psychosocial 
The patients were reassessed by 
personally on request. 









patients received psychotropic 
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medication where indicated, 
intervention which included: 
or a non-biological 
# crisis intervention or brief psychotherapy 
# couple or family sessions where needed. 
At the end of the 2 year period no further referrals were 
included in the study. Over the next 6 months patients 
in the study group were seen if referred. At the end of 
this 6 month period all patients in the sample including 
those that had died during the study were assessed by way 
of a folder analysis and discussion with the sister-in-
charge and the consultant physician. 
The second sample included 19 patients referred to me 
over a 2 year period by the Dept. of Radiotherapy, Groote 
Schuur Hospital. All patients were seen on an outpatient 
basis. The referral agent was unaware that these 
patients were part of a prospective study. Patients were 
referred by the clinical staff of the dept. of 
Radiotherapy. 
There was no sex or age restriction placed on patients 
ref erred for assessment. All 19 patients assessed had 
malignant disease. 
Lymphoma: 4 patients. 
Primary carcinoma: 5 patients. 
Metastatic carcinoma: 10 patients. 
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All patients referred were subjected to a standard 
psychiatric diagnostic interview. The identifying data 
was recorded. The clinical material obtained from the 
interview was analysed using the DSM III R criteria for 
diagnosis. 
As my role in the department was consultative unlike the 
Dept. of Haematology no follow up arrangements were made. 
A management strategy was devised at a clinical meeting 
held at the end of the outpatient session. Where 
necessary patients were referred to the appropriate 
resource in the Dept. of Psychiatry. 
At the end of the 2 year period all patients in the study 
including those who had died were assessed. This was 
done by way of a folder analysis and discussion with the 
relevant attending staff in the Dept. of Radiotherapy. 




# educational status 
# employment status 
# previous psychiatric contact 
# a significant psychological reaction 
# an Axis 1 diagnosis 
# type of Axis 1 diagnosis 
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# Axis 3 diagnosis 
# Pain 
# Axis 4 diagnosis pre and post diagnosis excluding 
losses 
# significant losses prior to diagnosis 
# use of psychotropics 
# use of psychological treatment strategies 
# an analysis of follow up visits in the haematological 
group 
# physical outcome 
# psychological outcome. 
For the purpose of understanding elaboration of the 




# EDUCATIONAL STATUS. 
This group was divided as follows: 
o = No formal education. 
1 = Primary Education(Sub.A - Std.5.) 
2 Secondary Education(Std.6 - Std 10.) 
3 = Tertiary Education(Completed Diploma/Degree course.) 
# EMPLOYMENT STATUS. 
This group was divided as follows: 
O Gainfully employed. 
1 = The patient receives an income either by way of a 
disability grant or pension. 
2 = Unemployment as direct result of the illness. 
3 = Unemployment. 
# SIGNIFICANT PSYCHOLOGICAL REACTION. 
This category was introduced for a group of patients who 
were sufficiently distressed to require psychiatric 
intervention but did not meet the DSM IIIR criteria for 
Axis 1 diagnosis. The reaction was an adjustment problem 
related to a stressor(s). 
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o = no reaction. 
1 a significant psychological reaction (SPR.). 
# AXIS 1 (PSYCHIATRIC DISORDER). 
This was divided into 5 main categories: 
o. = None. 
1. = Organic/structural. 
organic brain syndromes 
chronic (dementia). 
This category included 
both acute (delirium) 
all 
and 
2. = Organic/substance. This represents all patients 
with a substance (eg. alcohol, benzodiazepine, or 
cannabis.) abuse/dependence diagnosis. 
3. = Functional/Mood. This category included all 
4. 
patients with a mood disorder on a non organic or 
functional basis ie. Major Depression, Bipolar 
Disorder, and Adjustment Disorder with depressed 
mood. 
= Functional/Other. 
which is functional 
These patients have a disorder 
but unrelated to mood (eg. 
Adjustment Disorder with mixed emotions). 
5. = Mixed Organic/Functional - Mood. The category had 
an organic diagnosis coupled with a major mood 
disorder eg. Dememtia with Depression. 
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# AXIS 4 {STRESSORS). 
A significant psychological stressor(s) involves an event 
or enduring circumstance which has occurred in the year 
preceding evaluation and that may have contributed to the 
following: 
1. Development of a new mental disorder. 
2. Recurrence of a prior mental disorder. 
3. Exacerbation of an existing mental disorder. 
4. Development of a significant psychological reaction. 
Types of psychosocial stressors to be considered include: 
# Conjugal ( marital and non-marital) 
# Parenting. 
# Other interpersonal problems. 
# Occupational. 




# Physical illness or injury. 
# Family factors. 
Of importance is that the DSM IIIR scale for Severity of 
Psychosocial Stressors defines serious chronic illness in 
the category of extreme as a psychosocial stressor. 
These were assessed as follows: 
O.= None. 
44 
l.= Significant stressor(s) in the 12 month period prior 
to psychiatric assessment. 
significant stressors not associated with the Axis 3 
diagnosis: 
O.= a significant stressor(s) occurring in the 12 month 
period prior to assessment that remained 
unaddressed. 
l.= a significant new stressor(s) precipitating 
assessment. 
2.= no stressor apparent. 
# SIGNIFICANT LOSSES. 
The significant loss was the death of a family member, 
relative or very close friend in the 12 month period 




There was a significant difference between the Acute 
Leukaemia and the 2 Carcinoma groups (p < 0.02.). 
Acute Leukaemia Group 
Mean = 39 years 
Std.Dev.= 17 years 




There was no difference between the sexes with an 
approximate 1:1 ratio throughout the groups (32 males 
vs.30 females). 
3.03 EMPLOYMENT STATUS (APPENDIX 2 TABLE 2&3). 
50% of patients were gainfully employed. 23% of the 
total sample were unemployed with no income as a direct 
result of their illness. 
There appeared to be a trend for increasing educational 
status to be associated with increasing rates of gainful 
employment. 
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3.04 EDUCATIONAL STATUS (APPENDIX 2 TABLE 4). 
38% of the total sample had tertiary education and 47% 
secondary. Therefore 85% of the total sample had 
exposure to at least some form of secondary education. 
There were three patients interviewed who had no formal 
education. All three were unemployed with no income, 
secondary to their illness. 
3.05 PREVIOUS PSYCHIATRIC CONTACT (APPENDIX 2 TABLE 5). 
94% of the total sample had no prior psychological or 
psychiatric contact. 
3.06 SIGNIFICANT PSYCHOLOGICAL REACTION (SPR) NOT 
CLASSIFIED IN DSM IIIR (APPENDIX 2 TABLE 6). 
50% of the sample had a significant psychological 
reaction {SPR) related to a stressor(s). 13% of these 
patients were depressed. The majority of patients {37%) 
in this group presented with a mixed picture. Hence half 
the sample presented with a psychological reaction 
requiring some form of psychosocial intervention. 
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3.07 AXIS 1 PSYCHIATRIC DIAGNOSIS (APPENDIX 2 TABLE 7). 
37% of the total sample qualified for an Axis 1 
diagnosis. Although sample size is small there is no 
significant difference between the cancer subgroups. 
21% of the total sample had a significant mood disorder. 




a significant depression was present either 
in combination with another psychiatric 
3.08 PAIN AS A MAJOR PRESENTING FACTOR (APPENDIX 2 TABLE 
~ 
In 94% of the sample pain was not a significant factor. 
Three of the four patients presenting with pain as a 
prominent feature had metastatic carcinoma. 
3.09 PSYCHOSOCIAL STRESSORS (APPENDIX 2 TABLES 9-12 
INCLUSIVE) . 
47% of the sample 




a significant psychosocial 
month period prior to the 
48 
18% of the total sample had suffered a major loss within 
a 12 month period before the diagnosis of cancer. 
In 45% of the sample the stressor(s) identified at 
assessment had gone unnoticed. 40% of the sample 
presented with a significant precipitant stressor(s) not 
directly associated with the illness, its treatment or 
its prognosis. Hence 85% of the sample had stressors not 
directly associated with the illness, its treatment or 
prognosis. 
The reason for possible lack of overlap in Table 4c is 
that a significant psychosocial stressor (s) occurred in 
the 12 month period prior to psychiatric interview, 
whereas the significant loss(es) occurred in the 12 month 
period prior to physical diagnosis. 
3.10 PSYCHOTROPIC USAGE (APPENDIX 2 TABLES 13&14). 
66% of the total sample seen required no psychotropic 
medication. 
Of the remainder, 12 patients (58% of the patients 
prescribed a psychotropic) were prescribed a tricyclic on 
its own or in combination with a psychotropic usually a 
neuroleptic such as haloperidol. This correlates with 
the 57% presenting with an Axis 1 depressive disorder 
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either on its own or in combination with another 
psychiatric diagnosis. 
Hence antidepressants were the most frequently prescribed 
psychotropic medication in this sample of cancer 
patients. 
In 89% of the sample no patient was on a benzodiazepine 
at the time of interview. Of the 7 patients on 
benzodiazepines: 
# 3 patients were benzodiazepine dependent and were 
weaned off over a six week period 
# 3 patients were alcohol dependent and it was used for 
detoxification 
# in one patient lorazepam was prescribed when necessary 
sublingually prior to procedures for anxiety. 
Hence of the 7 patients requiring a benzodiazepine only 
one required ongoing medication for a specific indication 
and this on a dosage regimen controlled by the patient. 
3.11 PSYCHOLOGICAL INTERVENTION (APPENDIX 2 TABLE 15). 
In the haematological group: 
# 53% of the sample required one visit 
# 30% required between 1 - 4 visits 
# 8 patients of the total sample had 5 or more visits. 
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Hence 83% of the total sample required less than 5 
visits. This figure may be biased by the number of 
patients that died (18 or 38% in the haematological 
group). Despite this of the remaining 29 patients only 3 









intervention, at the time of completion of the study was 
effective in 25 patients or 86% of the haematological 
patients still alive at the end of the study period. 
3.12 PHYSICAL OUTCOME (APPENDIX 2 TABLE 16). 
44% of the total sample died during the study period. 
50% of the patients were either stable {34%) or in 
remission {16%). In 6% there was physical deterioration 
or relapse. This could imply that there was a bias in 
the sample referred, towards either terminal/preterminal 
illness, or patients on palliative treatment with no 
chance of cure. 16% of the total sample were in total 
remission or disease free at the time of referral. 
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3.13 PSYCHOLOGICAL OUTCOME (APPENDIX 2 TABLE 17). 












intervention and one patient had a recurrence of a Major 
Depressive Disorder, necessitating reintroduction of an 
antidepressant. There was no clear association between 
physical and psychological outcome as 4 of these patients 
were either in a stable physical condition or in 
remission. 
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12 6 4 1 
6 1 2 0 
4 1 2 0 
2 3 3 0 
2 0 2 1 
5 4 1 0 
31 15 14 2 
1(50%) (24%) (23%) (3%) 
KEY 
AXIS Ill 
1. Acute leukaemia 
2. Chronic leukaemia 
3. Myeloma 
4. Lymphoma 
5. Primary carcinoma 
6. Metastatic carcinoma 
EMPLOYMENT STATUS: 
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2. Grant/Pension 
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5 4 1. Acute leukaemia 
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2. Chronic leukaemia 
3. Myeloma 
4. Lymphoma 
3 5 5. Primary carcinoma 
6. Metastatic carcinoma 
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(47%) (38%) 3. Tertiary 
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TABLE 5. 
PREVIOUS PSYCHIATRIC CONTACT vs AXIS Ill 























2 1. Acute leukaemia 
2. Chronic leukaemia 
0 3. Myeloma 
4. Lymphoma 
0 5. Primary carcinoma 6. Metastatic carcinoma 
·-
0 
0. No previous psych.contact 
0 1. Previous psych.contact 
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3 AXIS Ill 
6 1. Acute leukaemia 2. Chronic leukaemia 
4 3. Myeloma 4. Lymphoma 
3 
5. Primary carcinoma 





































3 4 5 6 
5 5 3 6 
0 0 0 0 
1 0 2 1 
0 2 0 1 
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1. Acute leukaemia 
2. Chronic leukaemia 
3. Myeloma 
4. Lymphoma 
5. Primary carcinoma 
6. Metastatic carcinoma 
AXIS I 
0. None 
2. Organic - structural 
3. Functional mood 
4. Functional other 
5. Mixed organic/functional 
mood 












1. Acute leukaemia 
2. Chronic leukaemia 
3. Myeloma 
4. Lymphoma 
5. Primary carcinoma 
6. Metastatic carcinoma 
0. No pain 




TABLE 9 Significant Stressor in the 
12 month period prior to assessment 






















1. Acute leukaemia 
2. Chronic leukaemia 
3. Myeloma 
4. Lymphoma 
5. Primary carcinoma 
6. Metastatic carcinoma 
0. No significant stressor 
1. Significant stressor 
occurring in the 1 2 
month period prior to 
assessment not associated 
with the Axis Ill diagnosis 
TABLE 10. 
Significant loss(es) in the 12 month period 







1 21 2 
2 7 2 
3 5 2 
4 8 0 
5 3 2 
6 7 3 




1. Acute leukaemia 
2. Chronic leukaemia 
3. Myeloma 
4. Lymphoma 
5. Primary carc.inoma 
6. Metastatic carcinoma 
Significant loss 12 month 






Significant Stresses not associated 




Signif. Stress ors 
0 1 2 
1 10 8 5 
2 4 3 2 
3 4 3 0 
4 3 5 0 
5 2 2 1 
6 5 4 1 
28 25 9 




1. Acute leukaemia 
2. Chronic leukaemia 
3. Myeloma 
4. Lymphoma 
5. Primary carcinoma 
6. Metastatic carcinoma 
0. Signif. stressor not assoc. 
with the Axis Ill diagnosis 
occuring in the 12 month period 
prior to assessment that 
remained unnoticed. 
1. Signif. new stressor not associated 
with the Axis Ill diagnosis 
precipitating assessment 
2. No stressor apparent 
Significant Stresso rs in the 12 mth period 
prior to assessment vs Significant Losses 
prior to onset of illness 
... 
0 
















1. Signif. stressor within 
a 12 month period prior 
to assessment 
29c 47%) Signif. Loss 
0. None 
1. Signif. loss 12 month 
period prior to diagnosis 
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1. Acute leukaemia 
2. Chronic leukaemia 
3. Myeloma 
4. Lymphoma 
5. Primary carcinoma 




2. Antidepressant & 
another 
3. Another 
TABLE 14. BENZODIAZEPINES vs AXIS Ill 
Benzodiazepines 
0 1 2 3 KEY 
1 22 1 0 0 AXIS Ill 
2 9 0 0 0 1. Acute leukaemia 
2. Chronic leukaemia 
3 6 0 1 0 3. Myeloma 4. Lymphoma 
4 6 1 0 1 5. Primary carcinoma 6. Metastatic carcinoma 
5 4 0 1 0 Benzodiazepines 
6 8 1 1 0 0. No benzodiazepines prescribed 1. Weaned off group 
55 3 3 1 
2. Detoxification group 
3. Prescribed with specific indication 
(89%) (5%) (5%) (1%) 
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TABLE 15. HAEMATOLOGICAL GROUP 
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3. Myeloma 
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1 0 8 0 
3 1 1 2 
3 0 4 1 
1 0 2 2 
7 0 3 0 
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3. Myeloma 
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There was a significant age 
carcinoma and the leukaemia 
difference between 
groups. This is 
the 
not 
unexpected as the acute leukaemias tend to be an illness 
of young to middle aged adults. 
4.02 SEX. 
There was no difference between the sexes in terms of 
referral. 
4.03 EMPLOYMENT STATUS. 
Approximately half the patients were gainfully employed 
at the time of assessment. The majority of these 
patients had a matriculation or tertiary qualification. 
The above findings may have been the result of referral 
bias. However it is likely that other factors may have 
contributed to this association viz-: 
This group were primarily white collar workers who had a 
more sedentary form of employment coupled with greater 
employer support and better benefits. The employer was 
able to exercise greater flexibility in terms of job 
description and time allocation. The individual was also 
protected by benefits such as medical aid, and employment 
assurance. 
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Although the level of unemployment in S.A. is at present 
high, there needs to be greater company awareness of the 
plight of the blue collar worker. Future planning needs 
to take this into account. 
Maintaining employment is an important part of patient 
rehabilitation and gives the individual a sense of 
independence and purpose. It often acts as a useful 
source of distraction and social support making patients 
less dependent on family and community resources. 
4.04 EDUCATIONAL STATUS. 
As shown by the results over 80% of the sample had some 
form of secondary education or more. This is by no means 
representative of the general hospital community, even 
taking into account that most patients with malignant 
disease requiring radiotherapy and / or chemotherapy are 
treated by Groote Schuur Hospital, as there is no 
equivalent oncology service in the private sector. 
Possible reasons for this discrepancy are that: 
1. People with higher education are better able to 
communicate their distress verbally. 
2. The majority of professional staff are either 
English or Afrikaans speaking, creating a language 
barrier particularly for Xhosa speaking patients. 
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3. The majority of poorly educated come from the Xhosa 
language group. 
4. Cultural differences where some groups do not see it 
as a right to demand attention by enquiring about 
their wellbeing, or voicing their distress in any 
way. 
5. Insufficient effort made on the part of professional 
staff to enquire into the wellbeing of this group of 
patients? 






available for both 
and about the 
accessibility of community facilities available eg. 
National Cancer Association. 
The socially disadvantaged in 
diminished access to health care, 
this study have 
particularly with 
recent rapid urbanization and associated poor 
infrastructure. 
8. The escalating costs of heal th care even for the 
indigent population with the current state drive 
towards privatisation. 
Certainly more attention needs to be given to this area 
of patient management as many are surely needlessly 
suffering. These results reflect the findings of such 
workers as Kerner (9). Professional training should 
involve intiatives such as: 
# language classes in Xhosa 
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# greater understanding of traditional norms and values 
# greater awareness of the needs of the underpriviledged. 
The authorities must consider the introduction of 
translators, greater utilization of traditional healers, 
more involvement of existing community resources, and 
greater accessibility and affordability of services. 
4.05 AXIS 1 PSYCHIATRIC DIAGNOSIS. 
Of the total sample 63% had no Axis 1 diagnosis. 
The majority of patients presenting with an Axis 1 
diagnosis presented with a mood disorder {21% of the 
total sample). This group was equally divided between 
those with a functional mood disorder (n=7) and those and 
with a mixed presentation of an organic disorder either 
structural or substance in origin with an associated 
functional mood disorder (n=6). 
Three of the 6 patients presenting with Major Depressive 
Disorder had a recurrence of an existing disorder. Hence 
3 patients of the total sample presented with a single 
episode major depression associated with their malignant 
disease. The remaining 7 patients presented with an 
Adjustment Disorder with depressed mood. 
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Hence in this study the incidence of Major Depression 
associated with malignant disease was uncommon (n=3}. 
The majority of patients with emotional problems 
occurring during the course of their malignant disease 
presented with adjustment disorder or adjustment 
problems, the latter not classified in the DSM IIIR. 
These findings are consistent with those of other workers 
in the field (10 & 11). 
Of the total sample 19% (n=l2} had an organic component. 
In 7 patients this was related to a substance 
abuse/dependence problem predating the diagnosis of 
cancer. 
Of those presenting with a structural organic diagnosis 
(n=5}, 3 patients had a delirium. This latter condition 
not infrequently goes unnoticed by physicians 
particularly in the early phases when the main features 
centre around behavioural changes. 
Of interest was a 21 year old male who presented with all 
the features of Post Traumatic Stress Disorder. In view 
of this finding he was transferred to a 12 week programme 
in a Psychotherapeutic Milieu Unit for adolescents and 
young adults for further assessment and treatment. 
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As with others working in the field the shortcomings of 
the DSM IIIR as a diagnostic tool particularly in the 
area of mood disorder became apparent (11, 26, &28). One 
could not rely on the neurovegetati ve symptoms, such as 
anorexia and weight loss, as they frequently were related 
to the patient's underlying physical condition or 
treatment. The manual does not take into account the 
fact that a period of depression is to be expected and 
appropriate when for instance there is relapse of his/her 
illness. It is important to monitor patients at 
junctures such as these and watch for a persistence in 
depressive symptomatology. The manual does not take 
cognizance of the effect of treatment such as the 
discomfort or disfigurement associated with some forms of 
chemotherapy. 
Disfigurement was a theme with most patients interviewed 
although the study design did not take this issue 
specifically into account. For example hair loss in the 
patient, particularly female, during chemotherapy had a 
major impact and not infrequently appeared to cause the 
patient more concern than the illness itself. 
In the sample of patients interviewed suicidal ideation 
was never a major symptom except in one patient who was 
preterminal and on an antidepressant at the time of 
assessment for a recurrent major depressive disorder. 
When questioned most either denied suicidal ideation or 
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admitted to vague suicidal feelings. One can only 
speculate as to the reason for this. Possibly this 
formed part of their overall denial as a defense 
mechanism against a perceived life threatening situation. 
Another factor could be the will to live or survive as 
part of a normal reaction to the illness. 
4.06 SIGNIFICANT PSYCHOLOGICAL REACTION (SPR) NOT 
CLASSIFIED IN DSM IIIR. 
Of the total sample 50% presented with a significant 
psychological reaction (SPR) or adjustment problem, not 
classified in the DSMIIIR. In 26% of these patients the 
primary change was depressed mood. 
Although the majority of patients may not fulfil the DSM 
IIIR criteria for an Axis 1 psychiatric disorder they are 
sufficiently distressed to warrant some form of 
intervention. I feel that many of these patients go 
unnoticed and hence suffer unnecessarily. This is an 
important area for training staff as the symptoms and 
signs are not that obvious and underlying distress is 
often masked by problems associated with their malignant 
disease. Collateral from family is frequently useful in 
these situations and assists one in monitoring change. 
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4.08 STRESSORS. 
Of note was that 4 7% of the sample had a significant 
stressor ( s) in the 12 month period prior to the 
assessment interview. Aside from this another 18% 
suffered a major loss 12 months prior to the diagnosis. 
Sadly the majority of these stressors went unnoticed and 
hence were additional to the stressors normally 
associated with the investigation, diagnosis, management, 
and outcome of the illness. 
The above finding is of concern. Although many authors 
discuss the issue of disease related stress very little 
is discussed about stressors not associated with the 
illness or the impact of cumulative stress. 
Training in this area is sadly lacking with attending 
staff frequently focussing their attention on the tasks 
at hand which are usually disease or physical management 
related. 
This study showed the situation is unsatisfactory as 40% 
of the sample presented with a significant stressor(s) 
not associated with their illness or its prognosis. The 




Of note was that 47% of the sample had a significant 
stressor(s) in the 12 month period prior to the 
assessment interview. Aside from this another 18% 
suffered a major loss 12 months prior to the diagnosis. 
Sadly the majority of these stressors went unnoticed and 
hence were additional to the stressors normally 
associated with the investigation, diagnosis, management, 
and outcome of the illness. 
The above finding is of concern. Al though many authors 
discuss the issue of disease related stress very little 
is discussed about stressors not associated with the 
illness or the impact of cumulative stress. 
Training in this area is sadly lacking with attending 
staff frequently focussing their attention on the tasks 
at hand which are usually disease or physical management 
related. 
This study showed the situation is unsatisfactory as 40% 
of the sample presented with a significant stressor (s) 
not with their illness or its prognosis. The fact that 
the vast majority of these stressors go unnoticed only 
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adds to the patient's distress and increases their 
vulnerability to major psychopathology. 
This was a situation where a multiaxial approach such as 
adopted by the DSM IIIR is useful. It allows one to take 
a more holistic view of the situation and particularly 
address the needs of the individual patient. Of note is 
that the manual accords a serious chronic illness the 
status of an extreme stressor. I think this is important 
to bear in mind when one is carrying out an assessment 
because it draws attention to the underlying 
vulnerability to stress present in each every cancer 
patient. 
4.09 PSYCHOTROPIC USAGE. 





(66%). Of those 
requiring medication most were placed on an 
antidepressant. 
One should be circumspect before prescribing an 
antidepressant for a number of reasons mentioned below: 
1. Prior to using an antidepressant one must be sure of 
the diagnosis. This is often a difficult task in 








to their underlying 
cannot rely on 
neurovegetative symptoms as in physically healthy 
adults. It is often wise, if uncertain, to delay 
antidepressants until after one or two follow up 
visits. 
2. One must exclude pain as a contaminating factor in 
cancer patients. Pain control is essential before 
one can make an adequate assessment of the patient's 
mood status. 
3. Compliance is a major factor when prescibing 
psychotropics to cancer patients. Experience has 
shown that there is often a lot of resistance 
initially to starting medication. This is partly 
due to the stigma attached to psychiatric morbidity 
and the underlying denial of the problem. Adequate 
compliance is improved by devoting sufficient time 
to discussing mode of action of the product used and 
side effects. 
4. The choice of antidepressant is important in this 
group of patients because of possible undesirable 
effects 
treatment. 
associated with their illness and its 
These must be borne in mind. This area 
requires more research but some general principles 
should be adhered to when starting a product: 
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# gradual increase of the dose to a therapeutic level 
suitable for that individual remembering that the 
majority of cancer patients respond to a dosage less than 
that used in the physically healthy adult population. My 
experience is that patients with prior Major Depression 
may need full therapeutic doses as in the healthy adult 
population, 
# attempt to avoid products with anticholinergic 
properties because this may aggravate already unpleasant 
side effects the patient is experiencing. Patients are 
frequently on antiemetics such as prochlorpromazine while 
undergoing chemotherapy and/or radiotherapy and most have 
anticholinergic side effects. Patients on narcotic 
analgesia may already be constipated and this will only 
add to their discomfort. 
# cardiotoxici ty should be borne in mind before 
prescribing an antidepressant particularly the tricyclic 
group. One should enquire into the cardiac status of the 
patient and document the physical medication prescribed 
particularly chemotherapeutic agents (eg. 
cyclophosphamide) which have known cardiotoxic side 
effects. 
# the patient's progress must be adequately monitored 
especially in the initial stages of therapy. It should 
be emphasized that drug treatment is not a substitute for 
listening, counselling, or psychotherapy. 
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Antidepressants are useful in the 
particularly the tricyclic group. 
this setting is thought to be 
area of pain control 
The mode of action in 
unrelated to their 
antidepressant effect. Where appropriately used 
antidepressants can be a useful adjunct to treatment of 
pain. 
The benzodiazepine, lorazepam has been shown to effective 
in the area of anticipatory nausea and vomiting 
associated with chemotherapy and/or radiotherapy (34&35}. 
The usefulness of these agents in anticipatory anxiety 
needs to be further researched eg. in the area of 
investigatory procedures such as bone marrow aspiration. 
These products should not be prescribed without adequate 
supervision and monitoring. The dosage should be 
titrated to meet individual needs and the locus of 
control in terms of usage should be left wherever 
possible with the patient. 
4.10 PSYCHOLOGICAL INTERVENTION. 
Comments in this part of the discussion will only include 
those patients seen in the Dept. of Haematology. Of 
interest was that only half the sample required more than 
one visit. Of the sample 83% required less than 5 
visits. 
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It is important because it demonstrates that assessment 
and intervention is time effective and that the vast 
majority of these patients do not return for further 
follow up. 
Firstly the majority of patients with malignant disease 
are psychologically well-adjusted indi victuals. They are 
confronted by a major stressor in terms of a life 
threatening disease often compounded by superadded 
stressors not associated directly with their illness. In 
the study population most patients benefitted from a 
crisis type of intervention concentrating on the issues 
at hand. There was a cognitive bias to this form of 
input which was frequently educative and orientated 
towards problem solving. Only 17% of the sample required 
more than 5 visits. It was my feeling clinically that 
these patients benefitted 
psychotherapeutic intervention. 
improved symtomatology and better 
from this brief 
This was manifest by 
functioning in their 
lives both in the occupational and interpersonal sphere, 
especially with regard to intimate relationships. 
Secondly if staff are adequately trained in assessing 
problems and instituting management strategies much 
patient suffering can effectively be alleviated. Coupled 
with this will be the advantage of decreased patient 
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vulnerability and hence less likliehood of developing 
serious psychiatric morbidity. 
Thirdly staff will require adequate support in handling 
these problems. This is an area where the Liaison 
Psychiatrist can be utilized in organising feedback 
meetings which assist the staff in monitoring, managing, 
educating and supporting patients. Personally I have 
found these feedback meetings useful in increasing 
medical staff awareness and introducing a forum for 
discussion which is both educative and supportive. It 
also allows the staff to explore issues beyond the narrow 
confines of the biomedical model and hence develop a more 
holistic and frequently more realistic awareness of the 
patient's plight. 
The area of staff support needs considerable 
investigation. Little energy is devoted to this area and 
most reports are ancecdotal. Proper staffing of uni ts 
such as Radiotherapy Outpatients or the Haematology High 
Care Unit should be a priority with adequate cover in 
case of illness or leave. Enforced periods of leave and 
regular appraisal of working conditions such as hours 
worked and call rosters are mandatory. The introduction 
of support programmes is essential such as staff groups 
and stress management. These programmes must be directed 
at all levels of staff. Appropriate education programmes 
are imperative. 
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Burn out is a common phenomenon in this area. Sadly for 
the most part it goes unnoticed by the hospital 
authorities. (unpublished data.) Hospital personnel and 
administrative teams need greater awareness in this area 
of patient care including education about the demands on 
staff. Large outpatient loads are all too common in the 
oncology setting with inadequate staffing. 
Greater emphasis needs to be placed on the 
multidisciplinary team. This facilitates a coordinated 
management strategy. It also allows the patient to 
benefit from a broader range of opinion and therapeutic 
skills. 
Screening techniques which can be administered by 
attendant staff need to be developed. This would help in 
preventing unnecessary intervention delays and patient 
suffering and also allow one to monitor patient progress. 
4.11 PHYSICAL OUTCOME. 
As mentioned previously 44% of the sample died during the 
study period. Those remaining were either in a stable 
condition or in remission. As no physical parameters 





4.12 PSYCHOLOGICAL OUTCOME. 
on physical morbidity or 
Five patients deteriorated psychologically during the 
study. This followed initial assessment/intervention 
including a 6 month period after completion of the study. 
One of these patients had a recurrence of a Major 
Depression which responded to the reintroduction of an 
antidepressant. 
It is difficult to interpret the significance of this 
result and one can only speculate: 
# initial assessment/intervention addressed the problem 
successfully 
# the exposure of the issue heightened awareness of 
patient, staff and support system 
# there was improved patient monitoring by staff and the 
support system 
# there was improved communication between the parties 
involved 
# there was greater patient acceptability and hence an 
increased feeling of containment, and improved readiness 
to utilize the service. 
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4.13 CONCLUSION. 
The poor representation of the socially 
(although the sample size is small) is 
disadvantaged 
a matter of 
concern. A number of reasons have been put forward in 
all these is an urgent the discussion but underpining 
need to investigate this discrepancy. This could have a 
major impact on these disadvantaged members of the 
community. 
The incidence of major psychiatric morbidity appears to 
be no higher than that in the general population. The 
onset of malignant disease seems in some cases to lead to 
a recurrence of existing psychopathology. The majority 
of patients in the sample analysed presented with an 
adjustment problem or disorder. The DSM IIIR 
demonstrated its limitation as a diagnostic instrument 
particularly in the area of mood disorder where there is 
considerable overlap between psychiatric symptoms and the 
disease itself. It also does not make allowance for the 
effect of the disease process in cancer or its treatment. 
Of concern is the incidence of significant stressors 
predating the onset of malignant disease (including loss) 
which frequently go unaddressed. Staff appear to 
concentrate on the definable stressors associated with 
the diagnosis, 
personally feel 
investigation, management and outcome. I 
the whole entity of cumulative stress 
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needs to be addressed in the cancer setting. The area is 
important not only in the alleviation of unnecessary 
suffering in these patients but to diminish their 
vulnerability and predisposition to psychiatric 
morbidity. I feel the DSM IIIR is useful in this area as 
it draws attention to the underlying vulnerability of the 
cancer patient and makes one aware of stressors outside 
of the immediate implications of the disease process and 
its treatment. 
Psychotropic usage in this patient population must be 
judicious. Prior to prescription, the following must be 
assessed: 
# past psychiatric morbidity including family history of 
psychiatric illness 
# the influence of pain 
# underlying stressors. 
One must choose agents which are effective but at the 
same time do not add to the distress and physical 
suffering of the patient. Understanding side effect 
profiles of products used is important in this area as 
most cancer patients are on a number of physical agents 
at any one time; hence polypharmacy is the rule rather 
than the exception. 
This study demonstrated that psychological intervention 
is cost effective and does not overburden already 
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stressed staff. The majority of psychological 
interventions required under 5 follow up visits. These 
interventions were often helpful in alleviating 
suffering, assisting support systems and improving staff-
patient communication and compliance. 
This area could be better served by the development and 
introduction of reliable and valid screening 
questionaires which could be administered by attendant 
medical staff. These could identify problems and assist 
with ongoing monitoring of patient progress. 
There is an urgent need to focus on staff issues. There 
needs to be ongoing input in this area to increase 
awareness and ability in dealing with psychosocial 
problems. Educational input should be formal by way of 
seminars and tutorials and informal by using feedback 
sessions, psychosocial ward rounds, and discussion 
groups. 
A multidisciplinary team approach needs to be developed 
to allow for more comprehensive patient management. 
A neglected area is staff support where one could offer 
staff groups and adequate training before entering the 
field of oncology. Management awareness is vital in this 
area. 
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Psychosocial oncology is developing into a recognized 
discipline. The literature in this area is increasing 
and a solid body of well-researched knowledge is becoming 
available. The field has done much to enlighten the 
oncologist in the deficiencies of modern cancer care. It 
has highlighted the impact of the illness and its 
treatment on the patient and attendant psychosocial 
concerns. I think it has led to a more realistic 
appraisal of management strategies and takes the 
individual needs of each patient into account. 
It would appear that the problems confronting others are 
not dissimilar to the Groote Schuur setting. Of urgent 
need in our setting is increased awareness of the plight 
of the socially disadvantaged and the implementation of 
appropriate strategies to confront these issues including 
communication with the affected communities, increased 
awareness and attention to psychosocial needs, and 
improved staffing and staff education and support. 
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